Florida is shutting down its monoclonal antibody treatment sites after the Food and Drug Administration moved to revoke emergency authorization for treatments made by Eli Lilly (bamlanivimab and etesevimab, administered together) and Regeneron (REGEN-COV, or casirivimab and imdevimab), because data showed they are “highly unlikely to be active against the Omicron variant.”

Related posts:

Witness contacts police after woman swims into Biscayne Bay and disappears FBI Releases Photos Of Pompano Beach Bank Robbery Suspect People Mourning Loss Of Archbishop Desmond Tutu Remembering Betty White Shorty’s Dadeland sells land to developers in multi-million dollar deal